SI1047428T1 - Use of morpholinol for the treatment of sexual dysfunction - Google Patents

Use of morpholinol for the treatment of sexual dysfunction

Info

Publication number
SI1047428T1
SI1047428T1 SI9930976T SI9930976T SI1047428T1 SI 1047428 T1 SI1047428 T1 SI 1047428T1 SI 9930976 T SI9930976 T SI 9930976T SI 9930976 T SI9930976 T SI 9930976T SI 1047428 T1 SI1047428 T1 SI 1047428T1
Authority
SI
Slovenia
Prior art keywords
morpholinol
treatment
sexual dysfunction
sexual
dysfunction
Prior art date
Application number
SI9930976T
Other languages
Slovenian (sl)
Inventor
Phillip Frederick Morgan
David Lee Musso
John Joseph Partridge
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9801230.5A external-priority patent/GB9801230D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority claimed from EP99903200A external-priority patent/EP1047428B1/en
Publication of SI1047428T1 publication Critical patent/SI1047428T1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
SI9930976T 1998-01-21 1999-01-20 Use of morpholinol for the treatment of sexual dysfunction SI1047428T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9801230.5A GB9801230D0 (en) 1998-01-21 1998-01-21 Pharmaceutically active morpholinol
US7218098P 1998-01-22 1998-01-22
EP99903200A EP1047428B1 (en) 1998-01-21 1999-01-20 Use of morpholinol for the treatment of sexual dysfunction
PCT/US1999/001134 WO1999037305A1 (en) 1998-01-21 1999-01-20 Pharmaceutically active morpholinol

Publications (1)

Publication Number Publication Date
SI1047428T1 true SI1047428T1 (en) 2007-10-31

Family

ID=38325811

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930976T SI1047428T1 (en) 1998-01-21 1999-01-20 Use of morpholinol for the treatment of sexual dysfunction

Country Status (1)

Country Link
SI (1) SI1047428T1 (en)

Similar Documents

Publication Publication Date Title
GC0000096A (en) Treatment of female sexual dysfunction.
IS2494B (en) Use of morpholinol for the treatment of sexual dysfunction
EP1027057A4 (en) Treatment of female sexual dysfunction
PL343794A1 (en) Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
HRP980222B1 (en) Pyrazolopyrimidinones for the treatment of sexual disfunction
EP1143987A4 (en) Natural composition and method for the treatment of sexual dysfunction
GB9608408D0 (en) Treatment of erectile dysfunction
IL141553A0 (en) Drug preparations for treating sexual dysfunction
IL187030A0 (en) Use of retigabine for the treatment of neuropathic pain
HRP990195B1 (en) Intranasal formulations for the treatment of sexual disorders
AP9801414A0 (en) Combination effective for the treatment of impotence
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
EP1079764A4 (en) The treatment of sexual dysfunction in certain patient groups
AU5509099A (en) Pyridinones for the treatment of sexual dysfunction
IL162455A0 (en) Compounds for the treatment of sexual dysfunction
AU4676099A (en) Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
AU7652400A (en) Novel combination for the treatment of sexual dysfunction
PL362980A1 (en) Treatment of sexual dysfunction
AU8906201A (en) Methods and compositions for the treatment and prevention of sexual dysfunction
SI1047428T1 (en) Use of morpholinol for the treatment of sexual dysfunction
GB9904252D0 (en) Composition for the treatment of pain
ZA200006378B (en) Compounds for the treatment of female sexual dysfunction.
GB9813291D0 (en) Sexual dysfunction